Historical Background
G-protein-coupled receptors (GPCRs), also known as 7-transmemebrane domain receptors (7-TM receptors), have about 850 predicted members that act as cell surface messengers in response to extracellular signals, thus triggering intracellular signaling events (Kroeze et al. 2003). GPCRs are subject to activation by ligands, lights, hormones, neurotransmitters, odorants, or drug molecules, regulating various physiological functions including, but not limiting to, lipid metabolism and inflammation (Oh et al. 2010; Talukdar et al. 2011). Among these members, GPR120 was identified by searching the databases of rhodopsin-like GPCRs that belongs to the rhodopsin family of GPCRs and is conservative in human and mouse (Fredriksson et al. 2003). Until 2010,...
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fredriksson R, Höglund PJ, Gloriam DE, Lagerström MC, Schiöth HB. Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives. FEBS Lett. 2003;554(3):381–8.
Gong Z, Yoshimura M, Aizawa S. G protein-coupled receptor 120 signaling regulates ghrelin secretion in vivo and in vitro. Am J Physiol Endocrinol Metab. 2014;306(1):E28–35.
Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med. 2005;11:90–4.
Hudson BD, Shimpukade B, Mackenzie AE, Butcher AJ, Pediani JD, et al. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Mol Pharmacol. 2013;84:710–25.
Ichimura A, Hirasawa A, Godefroy OP, et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature. 2012;483:350–4.
Kazakos K. Incretin effect: GLP-1, GIP, DPP4. Diabetes Res Clin Pract. 2011;93:S32–6.
Kroeze WK, Sheffler DJ, Roth BL. G-protein-coupled receptors at a glance. J Cell Sci. 2003;116:4867–9.
Marzuillo P, Grandone A, Conte M, Capuano F, Cirillo G, et al. Novel association between a nonsynonymous variant (R270H) of the G-protein-coupled receptor 120 and liver injury in children and adolescents with obesity. J Pediatr Gastroenterol Nutr. 2014;59:472–5.
Miyauchi S, Hirasawa A, Iga T, Liu N, Itsubo C, et al. Distribution and regulation of protein expression of the free fatty acid receptor GPR120. Naunyn Schmiedeberg's Arch Pharmacol. 2009;379:427–34.
Mobraten K, Haug TM, Kleiveland CR, et al. Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells. Lipids Health Dis. 2013;12:101.
Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an ω-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142:687–98.
Oh DY, Walenta E, Akiyama TE, et al. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med. 2014;20:942–7.
Ozdener MH, Subramaniam S, Sundaresan S, Sery O, Hashimoto T, et al. CD36- and GPR120-mediated Ca2+signaling in human taste bud cells mediates differential responses to fatty acids and is altered in obese mice. Gastroenterology. 2014;146:995–1005.
Raptis DA, Limani P, Jang JH, Ungethum U, Tschuor C, et al. GPR120 on Kupffer cells mediates hepatoprotective effects of ω3-fatty acids. J Hepatol. 2014;60:625–32.
Talukdar S, Olefsky JM, Osborn O. Targeting GPR120 and other fatty acid sensing GPCRs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol Sci. 2011;32(9):543–50.
Tanaka T, Katsuma S, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G. Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedeberg's Arch Pharmacol. 2008;377:523–7.
Taneera J, Lang S, Sharma A, Fadista J, Zhou Y, et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 2012;16:122–34.
Watterson KR, Hudson BD, Ulven T, Milligan G. Treatment of type 2 diabetes by free fatty acid receptor agonists. Front Endocrinol. 2014;5:137.
Yan Y, Jiang W, Spinetti T, Tardivel A, et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity. 2013;38(6):1154–63.
Zhang D, So WY, Wang Y, Wu SY, Cheng Q, Leung PS. Insulinotropic effects of GPR120 agonists are altered in obese non-diabetic and diabetic states. Clin Sci. 2016;131:247–60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Wang, Y., Leung, P.S. (2018). GPR120. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_101625
Download citation
DOI: https://doi.org/10.1007/978-3-319-67199-4_101625
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67198-7
Online ISBN: 978-3-319-67199-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences